vs
Privia Health Group, Inc.（PRVA）与U S PHYSICAL THERAPY INC（USPH）财务数据对比。点击上方公司名可切换其他公司
Privia Health Group, Inc.的季度营收约是U S PHYSICAL THERAPY INC的2.7倍（$541.2M vs $202.7M）。U S PHYSICAL THERAPY INC净利率更高（2.0% vs 1.7%，领先0.4%）。Privia Health Group, Inc.同比增速更快（17.4% vs 12.3%）。过去两年Privia Health Group, Inc.的营收复合增速更高（14.2% vs 14.1%）
Privia Health Group, Inc.是总部位于美国的医疗科技与服务企业，为独立诊所、医疗系统和医疗支付方提供价值导向型医疗解决方案，涵盖人群健康管理、患者互动平台、护理协调支持及行政流程优化工具，助力提升诊疗效果、降低医疗参与方运营成本。
该企业是美国领先的门诊康复服务提供商，运营数百间线下物理治疗门诊，为受伤、术后、慢性疼痛及行动障碍人群提供康复护理，同时覆盖运动医学、职业治疗、儿童康复等特色服务领域。
PRVA vs USPH — 直观对比
营收规模更大
PRVA
是对方的2.7倍
$202.7M
营收增速更快
PRVA
高出5.1%
12.3%
净利率更高
USPH
高出0.4%
1.7%
两年增速更快
PRVA
近两年复合增速
14.1%
损益表 — Q4 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $541.2M | $202.7M |
| 净利润 | $9.2M | $4.2M |
| 毛利率 | — | 19.8% |
| 营业利润率 | 2.1% | 8.3% |
| 净利率 | 1.7% | 2.0% |
| 营收同比 | 17.4% | 12.3% |
| 净利润同比 | 108.0% | -55.1% |
| 每股收益（稀释后） | $0.08 | $-0.44 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PRVAUSPH
| Q4 25 | $541.2M | $202.7M | ||
| Q3 25 | $580.4M | $197.1M | ||
| Q2 25 | $521.2M | $197.3M | ||
| Q1 25 | $480.1M | $183.8M | ||
| Q4 24 | $460.9M | $180.4M | ||
| Q3 24 | $437.9M | $168.0M | ||
| Q2 24 | $422.3M | $167.2M | ||
| Q1 24 | $415.2M | $155.7M |
净利润PRVAUSPH
| Q4 25 | $9.2M | $4.2M | ||
| Q3 25 | $6.9M | $13.1M | ||
| Q2 25 | $2.7M | $12.4M | ||
| Q1 25 | $4.2M | $9.9M | ||
| Q4 24 | $4.4M | $9.2M | ||
| Q3 24 | $3.5M | $6.6M | ||
| Q2 24 | $3.5M | $7.5M | ||
| Q1 24 | $3.0M | $8.0M |
毛利率PRVAUSPH
| Q4 25 | — | 19.8% | ||
| Q3 25 | — | 18.7% | ||
| Q2 25 | — | 21.1% | ||
| Q1 25 | — | 16.9% | ||
| Q4 24 | — | 18.0% | ||
| Q3 24 | — | 17.3% | ||
| Q2 24 | — | 20.3% | ||
| Q1 24 | — | 18.2% |
营业利润率PRVAUSPH
| Q4 25 | 2.1% | 8.3% | ||
| Q3 25 | 2.5% | 12.8% | ||
| Q2 25 | 0.6% | 12.6% | ||
| Q1 25 | 1.1% | 10.7% | ||
| Q4 24 | 1.1% | 10.9% | ||
| Q3 24 | 1.3% | 7.6% | ||
| Q2 24 | 1.2% | 9.3% | ||
| Q1 24 | 0.2% | 9.6% |
净利率PRVAUSPH
| Q4 25 | 1.7% | 2.0% | ||
| Q3 25 | 1.2% | 6.7% | ||
| Q2 25 | 0.5% | 6.3% | ||
| Q1 25 | 0.9% | 5.4% | ||
| Q4 24 | 1.0% | 5.1% | ||
| Q3 24 | 0.8% | 3.9% | ||
| Q2 24 | 0.8% | 4.5% | ||
| Q1 24 | 0.7% | 5.2% |
每股收益（稀释后）PRVAUSPH
| Q4 25 | $0.08 | $-0.44 | ||
| Q3 25 | $0.05 | $0.48 | ||
| Q2 25 | $0.02 | $0.58 | ||
| Q1 25 | $0.03 | $0.80 | ||
| Q4 24 | $0.03 | $0.52 | ||
| Q3 24 | $0.03 | $0.39 | ||
| Q2 24 | $0.03 | $0.47 | ||
| Q1 24 | $0.02 | $0.46 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $479.7M | $35.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $737.2M | $476.4M |
| 总资产 | $1.4B | $1.2B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资PRVAUSPH
| Q4 25 | $479.7M | $35.6M | ||
| Q3 25 | $441.4M | $31.1M | ||
| Q2 25 | $390.1M | $34.1M | ||
| Q1 25 | $469.3M | $39.2M | ||
| Q4 24 | $491.1M | $41.4M | ||
| Q3 24 | $422.0M | $117.0M | ||
| Q2 24 | $387.4M | $112.9M | ||
| Q1 24 | $351.1M | $132.3M |
股东权益PRVAUSPH
| Q4 25 | $737.2M | $476.4M | ||
| Q3 25 | $709.1M | $503.6M | ||
| Q2 25 | $682.9M | $500.8M | ||
| Q1 25 | $659.4M | $497.3M | ||
| Q4 24 | $635.2M | $488.9M | ||
| Q3 24 | $614.9M | $482.8M | ||
| Q2 24 | $595.4M | $484.6M | ||
| Q1 24 | $576.8M | $479.8M |
总资产PRVAUSPH
| Q4 25 | $1.4B | $1.2B | ||
| Q3 25 | $1.4B | $1.2B | ||
| Q2 25 | $1.3B | $1.2B | ||
| Q1 25 | $1.2B | $1.2B | ||
| Q4 24 | $1.1B | $1.2B | ||
| Q3 24 | $1.1B | $1.0B | ||
| Q2 24 | $1.1B | $1.0B | ||
| Q1 24 | $1.0B | $1.0B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $127.5M | $24.9M |
| 自由现金流经营现金流 - 资本支出 | — | $21.0M |
| 自由现金流率自由现金流/营收 | — | 10.4% |
| 资本支出强度资本支出/营收 | — | 1.9% |
| 现金转化率经营现金流/净利润 | 13.93× | 6.00× |
| 过去12个月自由现金流最近4个季度 | — | $61.0M |
8季度趋势，按日历期对齐
经营现金流PRVAUSPH
| Q4 25 | $127.5M | $24.9M | ||
| Q3 25 | $52.0M | $19.9M | ||
| Q2 25 | $8.0M | $34.9M | ||
| Q1 25 | $-24.1M | $-4.7M | ||
| Q4 24 | $74.8M | $19.4M | ||
| Q3 24 | $33.2M | $22.1M | ||
| Q2 24 | $34.5M | $29.0M | ||
| Q1 24 | $-33.1M | $4.4M |
自由现金流PRVAUSPH
| Q4 25 | — | $21.0M | ||
| Q3 25 | — | $15.6M | ||
| Q2 25 | — | $31.6M | ||
| Q1 25 | — | $-7.3M | ||
| Q4 24 | — | $16.9M | ||
| Q3 24 | — | $19.6M | ||
| Q2 24 | — | $26.7M | ||
| Q1 24 | — | $2.6M |
自由现金流率PRVAUSPH
| Q4 25 | — | 10.4% | ||
| Q3 25 | — | 7.9% | ||
| Q2 25 | — | 16.0% | ||
| Q1 25 | — | -3.9% | ||
| Q4 24 | — | 9.4% | ||
| Q3 24 | — | 11.7% | ||
| Q2 24 | — | 15.9% | ||
| Q1 24 | — | 1.7% |
资本支出强度PRVAUSPH
| Q4 25 | — | 1.9% | ||
| Q3 25 | — | 2.2% | ||
| Q2 25 | — | 1.6% | ||
| Q1 25 | — | 1.4% | ||
| Q4 24 | — | 1.4% | ||
| Q3 24 | — | 1.5% | ||
| Q2 24 | — | 1.4% | ||
| Q1 24 | — | 1.2% |
现金转化率PRVAUSPH
| Q4 25 | 13.93× | 6.00× | ||
| Q3 25 | 7.58× | 1.52× | ||
| Q2 25 | 2.97× | 2.81× | ||
| Q1 25 | -5.70× | -0.47× | ||
| Q4 24 | 17.00× | 2.10× | ||
| Q3 24 | 9.38× | 3.34× | ||
| Q2 24 | 9.94× | 3.86× | ||
| Q1 24 | -11.10× | 0.55× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PRVA
| FFS Patient Care | $364.4M | 67% |
| Capitated Revenue | $71.4M | 13% |
| Shared Savings | $46.9M | 9% |
| FFS Administrative Services | $36.0M | 7% |
| Care Management Fee PMPM | $20.0M | 4% |
| Other Revenue | $2.5M | 0% |
USPH
| Net Patient Revenues | $169.7M | 84% |
| Industrial Injury Prevention Services Revenues | $28.9M | 14% |
| Management Contract Revenues | $2.3M | 1% |
